Five-year relative survival for chronic lymphocytic leukaemia (CLL) in men in England (67%) is similar to the average for Europe (68%). Wales (65%) and Scotland (72%) are also similar to the European average but Northern Ireland (51%) is below the European average. Across the European countries for which data is available, five-year relative survival in men ranges from 42% (Bulgaria) to 80% (Switzerland).
Five-year relative survival for CLL in women in England (73%) is similar to the average for Europe (74%). Wales (71%) and Northern Ireland (75%) are also similar to the European average but Scotland (81%) is above the European average. Across the European countries for which data is available, five-year relative survival in women ranges from 50% (Bulgaria) to 82% (France).
Chronic Lymphocytic Leukaemia (C91.1), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007
Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.
Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.
- De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34
About this data
Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, chronic lymphocytic leukaemia (C91.1).